Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 09, 2021 18:00 ET | Source: atai Life Sciences

atai Life Sciences to Host Conference Call and Webcast to Discuss Second Quarter 2021 Financial Results and Provide Business Update

BERLIN, Aug. 09, 2021 (GLOBE NEWSWIRE) -- atai Life Sciences N.V. (Nasdaq: ATAI) (“atai”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders,...
August 06, 2021 18:10 ET | Source: atai Life Sciences

atai Life Sciences to Present at the 41st Annual Canaccord Genuity Growth Conference

BERLIN, Aug. 06, 2021 (GLOBE NEWSWIRE) -- atai Life Sciences N.V. (Nasdaq: ATAI) (“atai”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders,...
July 29, 2021 09:19 ET | Source: Atai Life Sciences

atai Life Sciences gründet in Partnerschaft mit der University of Queensland InnarisBio mit dem Ziel, eine wirksamere nasale Verabreichungsmethode für atais Plattform therapeutischer Programme für mentale Gesundheit zu entwickeln

BERLIN und BRISBANE, Australien, July 29, 2021 (GLOBE NEWSWIRE) -- atai Life Sciences(„atai“ oder das „Unternehmen“) (Nasdaq: ATAI), ein biopharmazeutisches Unternehmen im klinischen Stadium, das...
July 28, 2021 09:12 ET | Source: atai Life Sciences

atai Life Sciences launches InnarisBio, in partnership with the University of Queensland, with the aim to develop a more effective nose-to-brain delivery method for atai’s platform of mental health therapeutic programs

BERLIN and BRISBANE, Australia, July 28, 2021 (GLOBE NEWSWIRE) -- atai Life Sciences (“atai” or the “Company”) (Nasdaq: ATAI), a clinical-stage biopharmaceutical company aiming to transform the...
July 07, 2021 19:47 ET | Source: atai Life Sciences

atai Life Sciences to Present at the Cowen Psychedelics & Novel Mechanisms in Neuropsychiatry Summit

BERLIN, Germany, July 07, 2021 (GLOBE NEWSWIRE) -- atai Life Sciences N.V. (Nasdaq: ATAI) (“atai”), a clinical-stage biopharmaceutical company developing psychedelic and non-psychedelic compounds...
June 17, 2021 23:21 ET | Source: atai Life Sciences

atai Life Sciences Announces Pricing of Upsized Initial Public Offering

BERLIN, June 17, 2021 (GLOBE NEWSWIRE) -- atai Life Sciences B.V. (Nasdaq: ATAI) (“atai”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders,...
June 11, 2021 07:59 ET | Source: atai Life Sciences

atai Life Sciences Announces Launch of Initial Public Offering

BERLIN, June 11, 2021 (GLOBE NEWSWIRE) -- atai Life Sciences B.V. (“atai”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, today announced the...